Revium Rx (RVRC) Retained Earnings (2024 - 2026)

Revium Rx has disclosed Retained Earnings across 3 years of filings, most recently posting $31.9 million for Q2 2026.

• In Q2 2026, Retained Earnings changed N/A year-over-year to $31.9 million; the TTM figure through Jun 2026 stood at $31.9 million (changed N/A YoY), while the FY2025 annual figure was $31.8 million, up 4.59% from the prior year.
• Retained Earnings came in at $31.9 million for Q2 2026 at Revium Rx, roughly flat from $31.8 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $31.9 million in Q2 2026 to a low of $30.4 million in Q4 2024.
• Average Retained Earnings over 3 years is $31.4 million, with a median of $31.8 million recorded in 2025.
• The largest YoY upside for Retained Earnings was 4.59% in 2025 against a maximum downside of 4.59% in 2025.
• Over 3 years, Retained Earnings stood at $30.4 million in 2024, then advanced by 4.59% to $31.8 million in 2025, then climbed by 0.35% to $31.9 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $31.9 million in Q2 2026, $31.8 million in Q4 2025, and $30.4 million in Q4 2024.